Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
about
Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemiaLRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1Adaptor proteins MiD49 and MiD51 can act independently of Mff and Fis1 in Drp1 recruitment and are specific for mitochondrial fission.Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophyCharcot-Marie-Tooth disease and intracellular trafficThe choreography of neuroinflammation in Huntington's diseasePhysiological and pathological significance of dynamin-related protein 1 (drp1)-dependent mitochondrial fission in the nervous systemPGC-1α, mitochondrial dysfunction, and Huntington's diseaseImpaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtinAlterations of mitochondrial dynamics allow retrograde propagation of locally initiated axonal insultsHuntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heartUbiquitin-dependent mitochondrial protein degradation.Mitochondrial Biology and Neurological DiseasesAbnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damageShaping the role of mitochondria in the pathogenesis of Huntington's diseaseMitochondrial dysfunction in neurodegenerative diseasesBiophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.Metabolic profiling for the identification of Huntington biomarkers by on-line solid-phase extraction capillary electrophoresis mass spectrometry combined with advanced data analysis tools.Decreased O-linked GlcNAcylation protects from cytotoxicity mediated by huntingtin exon1 protein fragmentD-β-hydroxybutyrate is protective in mouse models of Huntington's disease.Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis.The optic nerve: a "mito-window" on mitochondrial neurodegenerationIncreased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fissionDysfunctional mitochondrial respiration in the striatum of the Huntington's disease transgenic R6/2 mouse model.TOM40 mediates mitochondrial dysfunction induced by α-synuclein accumulation in Parkinson's disease.Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage.Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's diseaseImplications of mitochondrial dynamics on neurodegeneration and on hypothalamic dysfunction.Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.Dynamin-related protein 1 heterozygote knockout mice do not have synaptic and mitochondrial deficienciesOxidative metabolism in YAC128 mouse model of Huntington's disease.The emerging role of proteolysis in mitochondrial quality control and the etiology of Parkinson's disease.GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactionsMitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin.Mitochondria: the next (neurode)generationNovel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease PatientsImpaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease.
P2860
Q21132375-FA3BAA86-7FB0-4D36-9C36-391DF9423750Q24301357-520B765A-33D4-4812-8658-22B2E1BFFCF9Q24315659-F368BD61-EF01-498F-995F-903E6831C91AQ24621454-F9B03EB6-0F81-4F1F-87AD-F4A21EEAEB66Q26824841-E3460094-1E61-4869-BE5E-9DE280B7A3E6Q26828403-F8F37362-330F-4C0B-9D9D-60A94690C3DCQ26851430-6E3B2E54-44B9-4621-B662-B44B1FB06BDFQ27001671-CB0D098F-2EDE-48F8-8AC1-425E29099AF8Q27312215-6DB92146-26C9-47A3-AE8F-7DFE49DBFC22Q27312652-B0D75442-D91A-42F6-A729-BEE4608343DAQ27318284-D3859F57-1026-4A27-92C7-5449B495FAF9Q27692704-8BBFDDCB-E429-4100-8A8A-64D79F0E77FAQ28076942-784D5215-401A-4A5A-8CE7-DEFAFBC0A010Q28114981-7C55180B-16B9-49D2-8D46-EBDA204D3387Q28384036-9CE82895-DA70-4ECC-9161-EB0DB3687505Q28387647-2534F95D-65A7-4B4E-A400-BA4CF0E119EBQ30427825-5258E017-01E5-4E03-8476-8E926DA4265FQ31032933-A866AFD2-D0C4-47FD-B96B-13CF1F342B59Q33676752-7D37A6A8-3066-40B6-80A5-E84E04E15660Q34023773-FFB010A0-9461-4CAE-9F48-54C17CB84B9CQ34274478-F5618E45-7070-44E0-B138-CC5912DACC0DQ34298350-A311F0B0-A3E5-464A-9976-A512E865F0ADQ34313991-F50EB6F3-1305-402C-A9C8-6043235F571AQ34659907-93D5B1C1-63BA-4264-ADD6-2EA4504909C6Q34692945-022EC2D1-9D0C-4BDE-AA7B-2458418B2C9FQ35030813-F8307988-3582-44A5-B9FF-8F3718148002Q35126945-A4D63F58-D9A4-415F-A160-71C7E49568C9Q35256535-5DA29296-5813-4FD2-9B10-9346B13B5ACAQ35645271-8BD3F61D-A86D-4D1F-BAB9-474F2233A2DDQ35708874-A8E00156-A7F9-45C4-BC11-1934BBB04765Q35747131-0F413F5D-5AA2-4E46-8C15-F9E24E3A21FCQ35918643-8AEF56BF-D7FE-4BD6-92A6-779B147B7EFAQ35924062-6621C7F6-920D-4D28-859D-3EFDF544526DQ35986574-EE1FEE9D-BB04-48F2-A413-8A2A2644E7C0Q36002017-82AEB085-2BF1-4A05-94F9-82E6936FA285Q36026916-9D61AA45-279E-44D8-A505-712D5BE78CF0Q36080317-55474847-4ED5-4CF1-A433-2F18847166FEQ36124905-3E160988-380C-4292-80B6-7F6499BD171EQ36127832-703C881B-74DB-4622-82AD-DF781B659723Q36159463-174310EF-F33A-413D-A8B2-4999A875829C
P2860
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@ast
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@en
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@nl
type
label
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@ast
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@en
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@nl
prefLabel
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@ast
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@en
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@nl
P2093
P2860
P356
P1476
Abnormal mitochondrial dynamic ...... for selective neuronal damage.
@en
P2093
Arubala P Reddy
Danilo A Tagle
Marcus J Calkins
Maria Manczak
P Hemachandra Reddy
Peizhong Mao
Ulziibat Shirendeb
P2860
P304
P356
10.1093/HMG/DDR024
P577
2011-01-21T00:00:00Z